AGC Pharma Chemicals based in Spain and Japan is an innovative CDMO serving the global pharmaceutical industry with small molecule APIs and Intermediates.
The CDMO offers a one-stop shop service to customers, who can handle the lifecycle management of small molecules from grams to tons and from preclinical phase to commercialization, will expedite the delivery of life-changing new medicines to patients worldwide.
AGC Pharma Chemicals has more than 40 years’ experience as a small molecule CDMO and 60 years as API manufacture. Also offers high-quality chemical compounds by developing cost-efficient manufacturing processes in full compliance and cGMP international standards.

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Drug Substance Manufacturing (API);Research & Development;Clinical Trials materials and logistics;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

2

High Potent Products capabilities:

OEB 4-5

Facilities Locations:

Europe;East Asia

Regulatory Approvals for your facilities:

FDA (United States);EMA (Europe);ISO;GMP;PMDA (Japan)

Current Capacity:

AGC Pharma Chemicals is poised to support pharmaceutical clients with comprehensive solutions in drug development and manufacturing. For more information, visit agcpharmachemicals.com.